Stephan Rodrigo Marticorena Garcia1, Rosa Schmuck2, Bahra Marcus2, Christian Burkhardt1, Jing Guo1, Bernd Hamm1, Jürgen Braun3, and Ingolf Sack1
1Radiology, Charite - University Hospital Berlin, Berlin, Germany, 2Surgery, Charite - University Hospital Berlin, Berlin, Germany, 3Informatics, Charite - University Hospital Berlin, Berlin, Germany
Synopsis
Pancreatic
stiffness was investigated using multifrequency MR elastography (MRE) and
tomoelastography data processing in healthy controls (CTR) and patients with
pancreatic ductal adenocarcinoma (PDAC). In healthy volunteers,
tomoelastography was highly reproducible and showed no significant influences
of region and age on pancreatic stiffness. Furthermore, we show that PDAC can be
detected as stiff masses with full separation of MRE-values between CTR and
PDAC. MRE-based tumor volume correlated excellently with CT-volumetry. Tomoelastography
is well suited for boundary detection of pancreatic tumors within standardized,
quantitative and contrast-agent free imaging examinations.
Introduction:
Pancreatic ductal adenocarcinoma (PDAC) is the most common form of pancreatic cancer
with a rapid progression and poor 5-year survival rate 1. Detection for tumor boundaries based on precise stiffness-based
definition could support therapy planning and treatment monitoring in PDAC. PDAC have been reported to be stiffer
than normal-appearing pancreatic tissue 2,3 motivating the use of magnetic resonance elastography
(MRE) 4 for PDAC boundary detection. Therefore, we test novel
multifrequency MR elastography (MRE) and tomoelastography data
processing 5 based on multiple
pressurized-air drivers for its capability to precisely detect tumor
boundaries.Methods:
In this prospective study 27 healthy subjects (CTR, subdivided, based on
a cut-off of 50 years; HV-young, <50 years, n=14; HV-old, ≥50 years, n=13)
and 14 patients with histologically proven PDAC, subdivided into non-tumorous
(PDAC-NT) and tumorous (PDAC) regions) were investigated by multifrequency MRE and
tomoelastography processing 5. All experiments
were conducted on a 1.5 T MRI scanner equipped with a 12-channel phased array
surface coil. Three-dimensional wave fields at four frequencies between 30 and
60Hz acquired under free breathing within 5 min were induced by four
synchronized, pressurized-air driven actuators placed around the thorax (figure
1). Shear wave speed (SWS in m/s) as a surrogate of stiffness was measured in
the pancreas' head, corpus and tail. A subgroup of 9 randomly chosen healthy
volunteers were scanned twice, to assess the test-re-test variability using the
intraclass correlation
coefficient (ICC) and relative absolute difference (RAD). The diagnostic accuracy
was calculated for detection of PDAC. SWS-based tumor volumes (V-MRE) were
correlated with contrast-agent enhanced computed tomography (CT)-volumetry
(V-CT).Results:
Figure 2 shows representative elastograms (wave speed
maps) demonstrating a visual differentiation of PDAC with higher stiffness
values. Repeated measurements of 9 healthy volunteers showed a
high repeatability with an ICC of 0.79 and a RAD of 0.04.
No significant
influences of region (head, 1.23±0.12m/s; corpus, 1.23±0.11m/s; tail, 1.24±0.13m/s)
and age (CTR-young, 1.22±0.07m/s vs CTR-old, 1.25±0.12m/s, p=0.45; age vs SWS, r=0.15, p=0.46)
were discernable. PDAC (2.20±0.49 m/s; p<0.0001,
figure 3) was stiffer than CTR, without any overlap between both groups,
providing a cutoff of 1.5 m/s with a sensitivity and specificity of 100% and
100%, giving an AUROC of 1.0. Inner-patient analysis showed a higher stiffness
in PDAC compared to PDAC-NT (1.40±0.22m/s; p=0.001,
figure 3) and a cutoff of 1.6 m/s provides a sensitivity and specificity of 79%
and 93%, giving an AUROC of 0.94. Pa-NT was stiffer than control (p=0.01, figure 3). V-MRE (16.31±10.99 cm3)
correlated excellently (r=0.974; p<0.0001) with V-CT (18.37±15.75 cm3),
see figure 4.Discussion:
In our study cohort all PDAC were stiffer than normal
tissue implying a clear change of the biophysical tissue properties due to
tumor progression in the pancreas within distinct boundaries. From a
biophysical perspective, these boundaries are related to energy barriers which
have to be overcome by metastatic cells migrating into non-tumorous tissue. Tomoelastography
is a quantitative MRE method which generates contrast by the change of
wavelengths of shear waves e.g. when crossing through tumor boundaries. The
observed correlation between V-CT and V-MRE is an encouraging result
demonstrating that PDAC boundaries agree with perfusion-margins of the
CT-contrast agent. This suggests that MRE might be useful in the future as
endogenous-contrast based MRI technique for boundary mapping and tumor volume
quantification in PDAC. The obtained stiffness contrast might also be of value
for the differential diagnosis of malignant versus benign entities or mass
forming pancreatitis.
Our pilot study
reported normal values which can be used as control values for diagnosis. PDAC
are associated with SWS values above 1.5 m/s. This is in agreement to Shi et al 3 who reported 3.3 kPa
shear modulus which can be translated to SWS = 1.8 m/s (assuming 1 kg/L mass
density). Our normal parenchymal values also agree with Shi et al 3 and Kolipaka et al 6. Kolipaka et al also analyzed the regional
stiffness variation showing no effect 6 similar to our
findings. However, other than this group, we observed no age effect possibly
due to the low number of elderly subjects in our study cohort.
Conclusion:
In tomoelastography, stiff PDAC are highly contrasted by the very soft pancreatic
tissue favoring the use of tomoelastography for boundary detection of
pancreatic tumors within standardized, quantitative and contrast-agent free imaging
examinations.Acknowledgements
The authors would like to thank the German Research Foundation for financial
support (GRK2260, BIOQIC, SFB1340).References
1. Siegel RL, Miller KD,
Jemal A. Cancer statistics, 2015. CA Cancer J Clin 2015;65:5-29.
2. Shi Y, Cang L, Zhang X, et
al. The use of magnetic resonance elastography in differentiating autoimmune
pancreatitis from pancreatic ductal adenocarcinoma: A preliminary study. Eur J
Radiol 2018;108:13-20.
3. Shi Y, Gao F, Li Y, et al.
Differentiation of benign and malignant solid pancreatic masses using magnetic
resonance elastography with spin-echo echo planar imaging and three-dimensional
inversion reconstruction: a prospective study. Eur Radiol 2018;28:936-45.
4. Muthupillai R, Ehman RL.
Magnetic resonance elastography. Nat Med 1996;2:601-3.
5. Tzschatzsch H, Guo J,
Dittmann F, et al. Tomoelastography by multifrequency wave number recovery from
time-harmonic propagating shear waves. Med Image Anal 2016;30:1-10.
6. Kolipaka A, Schroeder S, Mo X, Shah Z,
Hart PA, Conwell DL. Magnetic resonance elastography of the pancreas:
Measurement reproducibility and relationship with age. Magn Reson Imaging
2017;42:1-7.